Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ultragreen AiFRA:U5T -4.59%31 Return-on-Tangible-Equity is 30.41% as of Jun. 2026, which is 71% below its 10-year median of 106.13. GuruFocus rates FRA:U5T with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 579 Healthcare Providers & Services companies, Ultragreen Ai ranks better than 81.17% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Ultragreen Ai's annualized net income for the quarter that ended in Jun. 2026 was €68.1 Mil. Ultragreen Ai's average shareholder tangible equity for the quarter that ended in Jun. 2026 was €224.0 Mil. Therefore, Ultragreen Ai's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2026 was 30.41%.
The historical rank and industry rank for Ultragreen Ai's Return-on-Tangible-Equity or its related term are showing as below:
FRA:U5T'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 45.08 Med: 106.13 Max: 132.65
Current: 45.08
During the past 4 years, Ultragreen Ai's highest Return-on-Tangible-Equity was 132.65%. The lowest was 45.08%. And the median was 106.13%.
FRA:U5T's Return-on-Tangible-Equity is ranked better than 81.17% of 579
companies
in the Healthcare Providers & Services industry
Industry Median: 10.68
vs FRA:U5T: 45.08
Ultragreen Ai (FRA:U5T) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Ultragreen Ai Return-on-Tangible-Equity Related Terms
Ultragreen Ai Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Ultragreen Ai's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:U5T vs VEEV, BTSG, HQY: Return-on-Tangible-Equity Comparison
For the Health Information Services subindustry, Ultragreen Ai's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ultragreen Ai Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ultragreen Ai's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Ultragreen Ai's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Jun. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 30.41% mean?
Ultragreen Ai (FRA:U5T) has a Return-on-Tangible-Equity of 30.41% as of Jun. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Ultragreen Ai and its competitors. This is 71% below median its historical median of 106.13. Over the past decade, Ultragreen Ai's Return-on-Tangible-Equity has ranged from 45.08 to 132.65. According to the industry distribution chart, Ultragreen Ai ranks #109 out of 579 companies in the Healthcare Providers & Services industry, placing it in the top 18.8%.
Is Ultragreen Ai's Return-on-Tangible-Equity too high?
Ultragreen Ai's current Return-on-Tangible-Equity of 30.41% is 71% below median its 10-year median of 106.13. Over the past 10 years, this metric has ranged from a low of 45.08 to a high of 132.65. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.68. Ultragreen Ai's value of 30.41% is 184.7% above this industry median. Based on the distribution chart, Ultragreen Ai ranks #109 out of 579 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Ultragreen Ai has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Ultragreen Ai's Return-on-Tangible-Equity compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Ultragreen Ai ranks #109 out of 579 companies for Return-on-Tangible-Equity. This places Ultragreen Ai in the top 19% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 10.68. Ultragreen Ai's value of 30.41% is 184.7% above this benchmark. Historically, Ultragreen Ai's own Return-on-Tangible-Equity has ranged from 45.08 to 132.65 over the past decade. While the company's 10-year median is 106.13 vs. the industry median of 10.68, Ultragreen Ai has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.68, based on 579 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ultragreen Ai's current Return-on-Tangible-Equity of 30.41% is 184.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Ultragreen Ai and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ultragreen Ai's current Return-on-Tangible-Equity is 30.41%, which is 71% below median its own 10-year median of 106.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ultragreen Ai stock overvalued right now?
Ultragreen Ai (FRA:U5T) has a current Return-on-Tangible-Equity of 30.41%. The current Return-on-Tangible-Equity is 30.41%, which is 71% below median its 10-year median of 106.13 and 184.7% above the Healthcare Providers & Services industry median of 10.68. Ultragreen Ai's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Ultragreen Ai (FRA:U5T), the current Return-on-Tangible-Equity is 30.41% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ultragreen Ai Ltd is engaged in the sales of Indocyanine Green (ICG) pharmaceutical products and cardiology Picture Archiving and Communication System (PACS) software and associated products and services. It provides a fluorescence imaging ecosystem designed to support surgeons with real-time perfusion data and visualization capabilities. The company is organised into business units based on its products and services and operates in (a) the Diagnostic Green (DxG) - Americas segment; (b) the DxG - Rest of the World segment; and (c) the UltraLinQ segment. The company generates the maximum of its revenue from the the DxG - Rest of the World segment, which focuses on the sales of ICG vials and related pharmaceutical products.
31GF Score
Get the complete analysis for FRA:U5T
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:U5T has been successfully added to your 
